Reversal by Pseudomonas aeruginosa of rifamycin SV inhibition of Staphylococcus aureus in vitro and in vivo.
D000818:Animals; D002478:Cells, Cultured; D066298:In Vitro Techniques; D051379:Mice; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa; D012294:Rifamycins / Q000494:pharmacology* / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013210:Staphylococcus / Q000187:drug effects*
D012294:Rifamycins